Ossium Health Stock

Ossium Health builds a bone marrow bank to treat blood cancers.

Sign up today and learn more about Ossium Health Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Ossium Health Stock

Ossium builds a bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation. The cells of the immune system are the human body’s natural defenders against disease. At Ossium, they are developing better methods of recovering, preserving, and deploying these critical cells to keep disease at bay.

Funding History

May 2018$10.4M
March 2021$63.0M
April 2023$3.5M
July 2023$52.0M

Management

CO-FOUNDER, CHIEF SCIENCE OFFICER

Erik Woods

CO-FOUNDER, PRESIDENT & CEO

Kevin Caldwell

Board Observer

Andrew Goldberg

Controller

Nick Niehaus

Board of Directors

Bill Trenchard

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo